References
- Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005;5:26. https://doi.org/10.1186/1471-2261-5-26
- Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 2011;164:559-67. https://doi.org/10.1530/EJE-10-1039
- Chiang JK, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord 2012;12:78. https://doi.org/10.1186/1471-2261-12-78
- Xiang S, Hua F, Chen L, Tang Y, Jiang X, Liu Z. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2013;121:115-8. https://doi.org/10.1055/s-0032-1333261
- Tola EN, Yalcin SE, Dugan N. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women. Eur J Obstet Gynecol Reprod Biol 2017; 214:168-72. https://doi.org/10.1016/j.ejogrb.2017.05.014
- Chan L, Xue H, Xiaoya Z, Jiajia X, Wei R, Linman L, et al. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in patients with adult growth hormone deficiency. Exp Clin Endocrinol Diabetes 2016;124:220-4. https://doi.org/10.1055/s-0035-1569402
- Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond) 2017;14:49. https://doi.org/10.1186/s12986-017-0206-2
- Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2012;54:700-13. https://doi.org/10.1097/MPG.0b013e318252a13f
- Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc 2017;92:251-65. https://doi.org/10.1016/j.mayocp.2016.09.017
- Neyzi O, Bundak R, Gokcay G, Gunoz H, Furman A, Darendeliler F, et al. Reference values for weight, height, head circumference, and body mass index in turkish children. J Clin Res Pediatr Endocrinol 2015;7:280-93. https://doi.org/10.4274/jcrpe.2183
- Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303. https://doi.org/10.1136/adc.44.235.291
- Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008;167:383-9. https://doi.org/10.1007/s00431-007-0502-3
- Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-3. https://doi.org/10.1542/peds.2004-1921
- Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009; 5:757-65.
- Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 2011;53:190-5. https://doi.org/10.1097/MPG.0b013e31821b4b61
- Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 2014;20:7392-402. https://doi.org/10.3748/wjg.v20.i23.7392
- Lee JH, Jeong SJ. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children? World J Pediatr 2017;13:248-54. https://doi.org/10.1007/s12519-017-0008-7
- Jain V, Jana M, Upadhyay B, Ahmad N, Jain O, Upadhyay AD, et al. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents. Indian J Med Res 2018;148: 291-301. https://doi.org/10.4103/ijmr.ijmr_1966_16
- Boyraz M, Hatipoglu N, Sari E, Akcay A, Taskin N, Ulucan K, et al. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obes Res Clin Pract 2014; 8:e356-63. https://doi.org/10.1016/j.orcp.2013.08.003
- Lin YC, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors for liver steatosis in obese children and adolescents. Pediatr Neonatol 2010;51: 149-54. https://doi.org/10.1016/S1875-9572(10)60028-9
- Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab 2015;100:4198-207. https://doi.org/10.1210/jc.2015-2527
- Nobili V, Alkhouri N, Bartuli A, Manco M, Lopez R, Alisi A, et al. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease. Pediatr Res 2010;67:665-70. https://doi.org/10.1203/PDR.0b013e3181da4798
Cited by
- Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population vol.18, pp.3, 2019, https://doi.org/10.3390/ijerph18030857
- Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review vol.22, pp.9, 2019, https://doi.org/10.3390/ijms22094807
- Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index vol.9, pp.1, 2022, https://doi.org/10.3390/children9010004